FDA Approved Products
| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|
| 213005 | NDA | LIQUIDIA TECH | | 001 | YUTREPIA | POWDER;INHALATION | EQ 0.0265MG BASE/INH | TREPROSTINIL SODIUM | 2025-05-23 | Prescription | Yes |
| 002 | YUTREPIA | POWDER;INHALATION | EQ 0.053MG BASE/INH | TREPROSTINIL SODIUM | 2025-05-23 | Prescription | Yes |
| 003 | YUTREPIA | POWDER;INHALATION | EQ 0.0795MG BASE/INH | TREPROSTINIL SODIUM | 2025-05-23 | Prescription | Yes |
| 004 | YUTREPIA | POWDER;INHALATION | EQ 0.106MG BASE/INH | TREPROSTINIL SODIUM | 2025-05-23 | Prescription | Yes |